Business Description
Klaria Pharma Holding AB
ISIN : SE0007280326
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 0.91 | |||||
Debt-to-EBITDA | -6.46 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.37 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 42.3 | |||||
3-Year EPS without NRI Growth Rate | 45.6 | |||||
3-Year FCF Growth Rate | 64.9 | |||||
3-Year Book Growth Rate | -42 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 90.36 | |||||
9-Day RSI | 82.15 | |||||
14-Day RSI | 76.15 | |||||
6-1 Month Momentum % | 7.29 | |||||
12-1 Month Momentum % | -53.6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.54 | |||||
Quick Ratio | 1.54 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.5 | |||||
Shareholder Yield % | -1.11 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 85.45 | |||||
Net Margin % | 682.86 | |||||
FCF Margin % | -20.61 | |||||
ROE % | -110.08 | |||||
ROA % | -60.38 | |||||
ROIC % | -7.07 | |||||
3-Year ROIIC % | -72.69 | |||||
ROC (Joel Greenblatt) % | -25.45 | |||||
ROCE % | -13.76 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 2.09 | |||||
PB Ratio | 3.06 | |||||
Price-to-Tangible-Book | 5.92 | |||||
Price-to-Free-Cash-Flow | 40.83 | |||||
Price-to-Operating-Cash-Flow | 40.83 | |||||
EV-to-EBIT | -20.6 | |||||
EV-to-Forward-EBIT | 1.01 | |||||
EV-to-EBITDA | -40.06 | |||||
EV-to-Forward-EBITDA | 1.01 | |||||
EV-to-Revenue | -17.99 | |||||
EV-to-Forward-Revenue | 0.45 | |||||
EV-to-FCF | 92.98 | |||||
Price-to-Net-Current-Asset-Value | 5.92 | |||||
Earnings Yield (Greenblatt) % | -4.86 | |||||
FCF Yield % | 1.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Klaria Pharma Holding AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | -0.587 | ||
EPS (TTM) (€) | -0.036 | ||
Beta | 1.69 | ||
Volatility % | 184.29 | ||
14-Day RSI | 76.15 | ||
14-Day ATR (€) | 0.009433 | ||
20-Day SMA (€) | 0.03301 | ||
12-1 Month Momentum % | -53.6 | ||
52-Week Range (€) | 0.0046 - 0.0754 | ||
Shares Outstanding (Mil) | 129.76 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Klaria Pharma Holding AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Klaria Pharma Holding AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Klaria Pharma Holding AB Frequently Asked Questions
What is Klaria Pharma Holding AB(STU:6FN)'s stock price today?
When is next earnings date of Klaria Pharma Holding AB(STU:6FN)?
Does Klaria Pharma Holding AB(STU:6FN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |